IP Library Patent Application 16917450
Patent Application
App. No. 16/917,450

Methods of Using Natural and Engineered Organisms to Produce Small Molecules for Industrial Application

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/917,450
Abstract

Aspects of the invention relate to methods of producing small molecules for industrial application using natural organisms and engineered organisms.

Claims (25)

1 .- 63 . (canceled)

64 . A method for producing and harvesting amino acids, comprising:

culturing in growth medium comprising a carbon-containing gas a bacterial cell that can grow in the presence of the carbon-containing gas,

wherein the bacterial cell is of the genus Cupriavidus or of the genus Rhodococcus,

wherein said carbon-containing gas is CO 2 ,

wherein said bacterial cell chemoautotrophically converts the CO 2 into amino acid products,

wherein said bacterial cell does not form poly-β-hydroxybutyrate (PHB) under chemoautotrophic growth conditions, and

wherein said bacterial cell secretes said amino acids products into the growth medium; and

separating the secreted amino acid products from the growth medium.

65 . The method of claim 64 , wherein the secreted amino acid products comprise lysine, tyrosine or phenylalanine.

66 . The method of claim 64 , wherein the bacterial cell is recombinant.

67 . The method of claim 66 , wherein the bacterial cell exhibits increased expression or activity relative to a wild type cell of an enzyme involved in lysine biosynthesis or in lysine secretion.

68 . The method of claim 67 , wherein the enzyme involved in lysine biosynthesis is an aspartate kinase or a dihydrodipicolinate synthase.

69 . The method of claim 67 , wherein the enzyme involved in lysine secretion is a lysine exporter.

70 . The method of claim 66 , wherein the bacterial cell exhibits decreased expression or activity relative to a wild type cell of one or more enzymes in the citric acid cycle.

71 . The method of claim 70 , wherein the enzyme in the citric acid cycle is succinyl-CoA synthase.

72 . The method of claim 66 , wherein the bacterial cell exhibits increased expression or activity relative to a wild type cell of an enzyme involved in the Shikimate pathway.

73 . The method of claim 72 , wherein the enzyme involved in the Shikimate pathway is chorismate synthase.

74 . The method of claim 64 , wherein the bacterial cell is a Cupriavidus necator cell or a Rhodococcus opacus cell.

75 . The method of claim 64 , wherein the bacterial cell is a Cupriavidus necator DSM 541 cell.

76 . The method of claim 64 , wherein the bacterial cell is an engineered cell that secretes at least 125 fold higher level of an amino acid than the corresponding wild type cell.

77 . The method of claim 76 , wherein the said amino acid is lysine.

78 . The method of claim 64 , wherein the bacterial cell is a mutant and/or engineered cell that secretes at least 2.5 fold higher level of an amino acid than the corresponding wild type cell.

79 . The method of claim 78 , wherein the said amino acid is an aromatic amino acid.

80 . The method of claim 79 , wherein the said aromatic amino acid is phenylalanine, tryptophan, tyrosine, and/or histidine.